Abstract:Abstract Background The RDW to albumin ratio (RAR) is a novel and simple biomarker of inflammation. The value of RAR in predicting acute HF prognosis has been suggested. However, its application in chronic HF was never investigated. Purpose To study the association of RAR with all-cause mortality in chronic HF. Methods We conducted a retrospective cohort study in patients followed in a HF clinic of a tertiary care academic hospital between January 2012 and December 2020. Consecutive adult patients with left ventricular systolic dysfunction (ejection fraction <50%) referred to the clinic were included. Patients with no measurement of RDW and no measurement of serum albumin were excluded from the analysis. The RAR was calculated as RDW (in %) / albumin (in g/dL). Patients were followed up to December 2022 and the endpoint under analysis was all-cause mortality. The association of RAR with mortality was assessed using a Cox-regression analysis. RAR was analysed as a continuous variable and as a categorical variable (cut-off 1st tertile). Multivariable models were built with adjustments to age, sex, arterial hypertension (AHT) history, diabetes mellitus (DM), atrial fibrillation (AF), ischaemic HF, severe left ventricular systolic dysfunction (LVSD), New York Heart Association class, systolic blood pressure (SBP), estimated glomerular filtration rate, haemoglobin, BNP, beta blocker (BB) use, angiotensin converting enzyme inhibitors or angiotensin receptor blockers (ACEi) or angiotensin receptor neprilysin inhibithors (ARB) use and mineralocorticoid receptor antagonist (MRA) use. Results We studied 754 patients, 63.3% male, mean age 71 (13) years, 64.1% had AHT history, 38.5% had DM, 33.3% had AF, HF was ischaemic in 44.4%, and 49.3% has severe LVSD. A total of 92.3% of the patients were on BB, 82.8% on ACEi or ARB or ARNi, and 29.7% on MRA. RAR presented a skewed right tailed distribution with a median value of 3.56, percentile 33.3 = 3.31 and percentile 66.7 = 3.85. During a median follow-up of 43 months 370 (49.1%) patients died. Mortality increased with increasing RAR: 33.2% in patients with ratio<3.31, 50.6% in patients with ratio 3.31 to <3.85 and 63.1% in patients with ratio≥3.85, p<0.001. The multivariate adjusted HR of all-cause death was 1.27 (95% CI: 1.12-1.43) per each unit increase in the RDW: albumin ratio. If RAR was analysed as a categorical variable, patients with RAR≥3.31 (1st tertile) presented an increased mortality risk of 1.48 (1.12-1.96); the increase in risk was independent of age, sex, comorbidities, LVSD, symptoms, SBP, haemoglobin, renal function, BNP and disease-modifying therapy. Conclusions The RAR is a strong and independent mortality predictor in chronic HF. Patients with a RAR ≥3.31 have a 48% increase in all cause-death in the long term; the increase in risk is of 27% per each unit rise in the ratio. Our results reinforce the importance of inflammation in chronic HF pathophysiology and progression.

Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure

Predictive Value of the Hb/RDW Ratio for the Risk of All-Cause Death in Patients with Heart Failure with Different Ejection Fractions

Red blood cell distribution width-derived indces predicts long-term prognosis in acute heart failure

The Ratio of Hemoglobin to Red Cell Distribution Width: A Strong Predictor of Clinical Outcome in Patients with Heart Failure

Association of Red Blood Cell Distribution Width and Hemoglobin-to-rdw Ratio with Contrast-Associated Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Retrospective Study

Prognostic Value of Red Blood Cell Distribution Width for Patients with Heart Failure: a Systematic Review and Meta-Analysis of Cohort Studies.

Prognostic value of hemoglobin-to-red cell distribution width ratio in cancer: a systematic review and meta-analysis

Red cell distribution width predicts short- and long-term outcomes of acute congestive heart failure more effectively than hemoglobin

Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Mortality in Patients with HBV-Related Decompensated Cirrhosis

Correlation between peripheral blood hemoglobin/erythrocyte distribution width ratio and prognosis of patients with primary colorectal cancer

The Hemoglobin-to-Red Cell Distribution Width Ratio to Predict All-Cause Mortality in Patients with Sepsis-Associated Encephalopathy in the MIMIC-IV Database

Red Cell Distribution Width is Associated with Short‐term Mortality in Critically Ill Patients with Heart Failure

Prognostic Impact of the Ratio of Hemoglobin to Red Blood Cell Distribution Width in Patients after Acute Decompensated Heart Failure

Association between red blood cell distribution width‐to‐albumin ratio and prognosis in non‐ischaemic heart failure

Red Cell Distribution Width is Associated with Hospital Mortality in Unselected Critically Ill Patients.

Predictive role of red blood cell distribution width and hemoglobin-to-red blood cell distribution width ratio for mortality in patients with COPD: evidence from NHANES 1999-2018

Differences in the Predictive Value of Red Cell Distribution Width for the Mortality of Patients with Heart Failure Due to Various Heart Diseases

Red cell distribution width (RDW) to serum albumin ratio (RAR) in chronic heart failure

Preoperative Hemoglobin-to-red Cell Distribution Width Ratio As a Novel Prognostic Parameter in Hepatocellular Carcinoma after Curative Resection.

Red blood cell distribution width/albumin ratio is a novel risk factor of incidence and long-term mortality in chronic heart failure patients: three large cohorts from China and America.

Usefulness Of Red Blood Cell Distribution Width To Predict Heart Failure Hospitalization In Patients With Hypertrophic Cardiomyopathy